+ Translate
+ Most Popular
The pigeon tick (Argas reflexus): its biology, ecology, and epidemiological aspects
Prevalence of hemoglobin abnormalities in Kebili (Tunisian South)
Lipogranuloma: a preventable complication of dacryocystorhinostomy
Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency
Bees from the Belgian Congo. The acraensis group of Anthophora
Placing gingival retraction cord
Total serum IgE, allergy skin testing, and the radioallergosorbent test for the diagnosis of allergy in asthmatic children
Acariens plumicoles Analgesoidea parasites des oiseaux du Maroc
Injuries of terminal phalanges of the fingers in children
Biology of flowering and nectar production in pear (Pyrus communis)
Das Reliktvorkommen der Aspisviper (Vipera aspis L.) im Schwarzwald
Hydrological modelling of drained blanket peatland
Pathologic morphology and clinical significance of the anomalous origin of the left circumflex coronary artery from the right coronary artery. General review and autopsy analysis of 30 cases
Cyto genetic analyses of lymphocyte cultures after exposure to calcium cyclamate
Axelrodia riesei, a new characoid fish from Upper Rio Meta in Colombia With remarks concerning the genus Axelrodia and description of a similar, sympatric, Hyphessobrycon-species
Favorable evolution of a case of tuberculosis of pancreas under antibiotic action
RIFM fragrance ingredient safety assessment, Valencene, CAS Registry Number 4630-07-3
Parenteral microemulsions: an overview
Temperate pasture: management for grazing and conservation
Evaluation of a new coprocessed compound based on lactose and maize starch for tablet formulation
Thermal expansion and cracking of three confined water-saturated igneous rocks to 800C
Revision of the genera of the tribe Stigmoderini (Coleoptera: Buprestidae) a discussion of phylogenetic relationships
Anal tuberculosis. Report of a case
Gastric tuberculosis in the past and present
Adaptive responses of the cardiovascular system to prolonged spaceflight conditions: assessment with Holter monitoring

Comparison of protection from homologous cell-free vs cell-associated SIV challenge afforded by inactivated whole SIV vaccines

Comparison of protection from homologous cell-free vs cell-associated SIV challenge afforded by inactivated whole SIV vaccines

Journal of Medical Primatology 21(2-3): 126-130

ISSN/ISBN: 0047-2565

PMID: 1433263

This study attempted to determine if SIV vaccines could protect against challenge with peripheral blood mononuclear cells (PBMCs) from an SIV infected rhesus monkey. Mature Macaca mulatta were vaccinated four times with formalin inactivated SIVmac32H administered in MDP adjuvant (n = 8) or SIVmac32H ISCOM vaccine (n = 8). Controls included animals vaccinated with measles virus in MDP adjuvant (n = 4) or ISCOM (n = 4) preparations. Of each group, half were challenged intravenously (IV) with ten MID50 of the cell-free SIVmac32H (11-88) SIV stock and half were challenged with ten MID50 of PBMCs from the SIVmac32H infected macaque 1XC. All SIV vaccinated animals challenged with the 11-88 cell free stock of SIVmac32H were protected, whereas only half of the SIV vaccinated monkeys receiving the same infectious dose of the 1XC cell stock were protected.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 039632465

Download citation: RISBibTeXText

Related references

Comparison of protection afforded by whole virus ISCOM versus MDP adjuvanted formalin-inactivated SIV vaccines from IV cell-free or cell-associated homologous challenge. Aids Research and Human Retroviruses 8(8): 1507-1510, 1992

Protection of rhesus macaques from cell free and cell associated siv challenge by vaccination with siv iscoms or mdp adjuvanted inactivated siv. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : we 52, 1992

Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines. Journal of Virology 69(2): 1253-1255, 1995

Comparison of hamster and pony challenge models for evaluation of effect of antigenic drift on cross protection afforded by equine influenza vaccines. Equine Veterinary Journal 35(5): 458-462, 2003

Limits of protective immunity generated by SIVmne gp160 vaccines against cell-free homologous virus challenge. AIDS Research and Human Retroviruses 10(Suppl. 2): S137, 1994

An evaluation of the cross-protection afforded by inactivated infectious coryza vaccines. Australian Veterinary Journal 68(8): 266-267, 1991

Comparison testing of acetone inactivated bacterial and precipitated cell free typhoid tetanus vaccines. Annales Immunologiae Hungaricae 11: 43-49, 1968

Passive protection afforded by maternally-derived antibodies in chickens and the antibodies' interference with the protection elicited by avian influenza-inactivated vaccines in progeny. Avian Diseases 54(1 Suppl): 246-252, 2010

Protection afforded chickens against Marek's disease lymphomas by vaccination with cell-free or cell-associated turkey herpesvirus vaccine. Resistance and immunity to Marek' s disease: 500-516, 1980

Protection of macaques against simian immunodeficiency virus infection with inactivated vaccines: Comparison of adjuvants, doses and challenge viruses. Vaccine 13(3): 295-300, 1995

Protection afforded against aerosol challenge by systemic immunisation with inactivated Francisella tularensis live vaccine strain (LVS). Microbial Pathogenesis 44(2): 164-168, 2008

Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. Journal of Immunology 149(3): 981-988, 1992

Protection to mice afforded by BCG vaccines against an aerogenic challenge by three mycobacteria of decreasing virulence. Tubercle 66(4): 267-276, 1985

Inactivated whole virus vaccine derived from a proviral dna clone of siv induces protection against challenge with cell free virus but not infected cells. Brown, F , Et Al (Ed ) Vaccines (Cold Spring Harbor), 92 Modern Approaches to New Vaccines Including Prevention Of Aids; Ninth Annual Meeting, Cold Spring Harbor, New York, Usa, September 19-23, 1991 Xxiii+408p Cold Spring Harbor Laboratory Press: Plainview, New York, Usa Illus Paper 95-102, 1992

Protection of chickens afforded by commercial lentogenic vaccines against challenge exposure to velogenic Newcastle disease virus. Avian Diseases 17(2): 279-282, 1973